Nuveen, LLC Allogene Therapeutics, Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 215,366 shares of ALLO stock, worth $348,892. This represents 0.0% of its overall portfolio holdings.
Number of Shares
215,366Holding current value
$348,892% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ALLO
# of Institutions
170Shares Held
150MCall Options Held
75.8KPut Options Held
52.8K-
Tpg Gp A, LLC Fort Worth, TX18.7MShares$30.3 Million1.1% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$26.6 Million0.0% of portfolio
-
Capital World Investors Los Angeles, CA12.3MShares$19.9 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR10.9MShares$17.6 Million9.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.07MShares$13.1 Million0.0% of portfolio
About Allogene Therapeutics, Inc.
- Ticker ALLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 143,807,008
- Market Cap $233M
- Description
- Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...